Trials
Search / Trial NCT05647174

MGPOCUS Assisted Bronchoscopy in Difficult Endotracheal Intubation

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Dec 3, 2022

Trial Information

Current as of February 05, 2025

Not yet recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged between 18 and 85 years old.
  • Requiring ETI.
  • Anticipated DTI meets one or more positive findings in the airway evaluation, including history, examination, and appropriate investigations of anatomy .
  • Signed written informed consent.
  • Willingness for the primary anesthesia team to participate.
  • Exclusion Criteria:
  • Anterior neck lesions (masses, lacerations, or subcutaneous emphysema).
  • A history of neck operation or tracheotomy.
  • Allergies to ultrasound coupling gel.
  • At risk of pulmonary or cardiovascular complications during intubation with flexible bronchoscope, including severe hypoxemia, severe pulmonary hypertension, unstable or severe obstructive airway disease.
  • At risk of bleeding during bronchoscope, including anticoagulants or coagulopathy, renal insufficiency, and superior vena cava syndrome.
  • High risk of aspiration.
  • Current pregnancy.
  • Patient unable to cooperate (for awake intubation).

About Peking Union Medical College Hospital

Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.

Locations

Beijing, , China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials